Results 141 to 150 of about 3,569 (208)

Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati syndrome: an international rare disease registry study.

J Clin Endocrinol Metab
Almutair A, Karas K, Al Subaihin A, Al Dibasi O, Melha M, Al-Ghamdi H, Yadav B, Al Ghanam S, Alanazi A, AlSaedi A, Althobaiti E, Al Senani A, Al Azkawi H, Al Enezi A, Bakkar A, Ali A, Al Juraibah F, Alyaarubi S, Al Sagheir A, Högler W.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alfacalcidol in the treatment of oateoporosis

1998
To evaluate the efficacy and safety of alfacalcidol, we conducted a two-years study in 32 women who had clinical and roentgenological signs of osteoporosis. All randomly assigned women received treatment with One Alpha (alfacalcidol) 0.25 mg twice a day (LEO Pharmaceutical Products A/S Denmark).
Krasauskienė, Aurelija, Lašas, Liudvikas, Lašienė, Danutė Teresė   +2 more
openaire   +2 more sources

Alfacalcidol

Reactions Weekly, 2021
openaire   +1 more source

Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial

Journal of Clinical Endocrinology and Metabolism, 2021
Ravinder Goswami, Vishnubhatla Sreenivas
exaly  

Alfacalcidol

Reactions Weekly, 2005
openaire   +1 more source

Alfacalcidol

Reactions Weekly, 2013
openaire   +1 more source

Alfacalcidol/phosphorus

Reactions Weekly, 2023
openaire   +1 more source

Alfacalcidol

Reactions, 1989
openaire   +1 more source